Rankings
▼
Calendar
REVB Q3 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6,765
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-1.77
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$874
Balance Sheet
Total Assets
$13M
Total Liabilities
$2M
Stockholders' Equity
$11M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6,765
-$7,220
+6.3%
Operating Income
-$2M
-$2M
-8.1%
Net Income
-$2M
-$2M
+14.9%
← FY 2025
All Quarters
Q4 2025 →